PHIBRO (PAHC) CFO David Glenn Receives 3,482 RSU Award

What Happened David Glenn, Chief Financial Officer of Phibro Animal Health Corp (PAHC), was granted 3,482 restricted stock units (RSUs) on August 6, 2026. The RSUs were reported as acquired at $0.00 (i.e., no cash paid). This filing is an amendment correcting the number of RSUs originally reported.

Key Details

• Transaction type: Award/Grant (code A) of 3,482 RSUs on 2026-08-06, reported in an amended Form 4 filed 2026-09-17 (original Form 4 filed 2026-08-10).
• Reported acquisition price: $0.00 per RSU; total reported cash cost $0.
• Footnote highlights:
  • Each RSU represents a contingent right to receive one share of Class A common stock upon vesting.
  • RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to continued employment.
  • The amendment corrects an earlier understatement of the RSU grant due to a calculation error.
• Shares owned after the transaction: Not specified in the information provided with this filing.

Context RSUs are a form of equity compensation that convert to actual shares only upon vesting; they do not represent an immediate market purchase or sale. The award itself does not necessarily signal buying or selling sentiment—its value to the insider depends on Phibro’s stock price at each vesting date. The amendment simply corrects the originally reported grant size; review the company’s previous disclosures if you want the full history of insider holdings.